Ann Clin Case Rep | Volume 6, Issue 1 | Case Report | Open Access

Hyper- or Pseudoprogression? A Case Report of MSI-High Metastatic Colorectal Cancer

Schuler A1*, Omlin A1, Husarik D2, Denecke B1 and Rothermundt C1

1Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland 2Department of Radiology and Nuclear Medicine, Cantonal Hospital St. Gallen, Switzerland

*Correspondance to: Schuler A 

Fulltext PDF

Abstract

About 4% to 8% of patients with metastatic Colorectal Cancer (CRC) harbor deficient Mismatch Repair proteins (dMMR) and/or high Microsatellite Instability (MSI-H). We present the case of a patient with somatic dMMR (loss of MLH1 and PMS2), MSI-Hand BRAF V-600E mutated metastatic right-sided colon cancer treated with an Immune Checkpoint Inhibitor (ICI), who had radiological signs of Hyperprogressive Disease (HPD) with also an increase in tumour marker levels, followed by a Complete Remission (CR).

Keywords:

Colorectal cancer; Hyperprogression; Immune checkpoint inhibitor therapy; Microsatellite instability; Pseudoprogression

Citation:

Schuler A, Omlin A, Husarik D, Denecke B, Rothermundt C. Hyper- or Pseudoprogression? A Case Report of MSI-High Metastatic Colorectal Cancer. Ann Clin Case Rep. 2021; 6: 2054..

Subscribe to Our Newsletter